Hyun, S. Y., Han, S. H., Kim, S., Jang, J. E., Kim, Y., Cho, H., . . . Kim, J. S. (2016). Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens. J Korean Med Sci.
Dyfyniad Arddull ChicagoHyun, Shin Young, et al. "Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients With Multiple Myeloma During Treatment With Bortezomib-based Regimens." J Korean Med Sci 2016.
Dyfyniad MLAHyun, Shin Young, et al. "Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients With Multiple Myeloma During Treatment With Bortezomib-based Regimens." J Korean Med Sci 2016.